Qualitative analysis of the humoral immune response to the “a” determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine
- 1 February 1987
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 21 (2) , 155-160
- https://doi.org/10.1002/jmv.1890210207
Abstract
Competitive inhibition assays using monoclonal antibodies reacting with defined sequence of the “a” determinant of hepatitis B surface antigen (HBsAg) indicate that the humoral response to plasma-derived and recombinant HBsAg vaccine is similar in quantitative and qualitative terms. Both vaccines evoke an antibody response to the RFHBs 1 epitope, which is known in animal experiments to be protective.Keywords
This publication has 11 references indexed in Scilit:
- Safety and immunogenicity of a recombinant hepatitis B vaccineJournal of Medical Virology, 1985
- Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the ChimpanzeeJournal of Medical Virology, 1985
- Standardization of the antibody to hepatitis B surface antigen concentrationJournal of Biological Standardization, 1985
- IMMUNOGENICITY OF RECOMBINANT YEAST HEPATITIS B VACCINEThe Lancet, 1985
- Immunogenicity of a five‐microgram dose of hepatitis B vaccineJournal of Medical Virology, 1985
- CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1984
- AFFINITY OF ANTIBODY RESPONSES IN MAN TO HEPATITIS B VACCINE DETERMINED WITH SYNTHETIC PEPTIDESThe Lancet, 1984
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980